The niche-metabolism axis: reprogramming tumor-associated macrophages for precision immunotherapy.
This framework highlights that therapeutic paradigms should shift from nonselective TAM depletion to niche-specific metabolic-epigenetic reconstruction, providing a precise roadmap for designing next-generation engineered macrophage therapies.